Cargando…

Establishing Health Biotech and Enhancing Local Manufacturing of Pharmaceuticals in Sub-Saharan Africa

Although many nations in Sub-Saharan Africa (SSA) have recently recorded impressive economic growth, and several countries could attain middle-income status in the next decade, there is no or little concurrent advance in health biotech with little capabilities for manufacturing of medicines, medical...

Descripción completa

Detalles Bibliográficos
Autor principal:	Balcha, Taye T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Viewpoint
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236473/ https://www.ncbi.nlm.nih.gov/pubmed/30450268 http://dx.doi.org/10.1177/2164956118809685

Ejemplares similares

The collateral damage of the COVID-19 pandemic on surgical health care in sub-Saharan Africa
por: Chu, Kathryn, et al.
Publicado: (2020)

Reducing maternal mortality in sub–Saharan Africa: the role of ethical consumerism
por: Wijeratne, Dileep, et al.
Publicado: (2017)

Reframing the approach to heterosexual men in the HIV epidemic in sub‐Saharan Africa
por: Makusha, Tawanda, et al.
Publicado: (2020)

Improving Child Survival in Sub-Saharan Africa: Key Environmental and Nutritional Interventions
por: Amegah, A. Kofi
Publicado: (2020)

Setting Up a Medical Oncology Educational Program in Sub-Saharan Africa
por: Bravaccini, Sara, et al.
Publicado: (2021)

E-Learning for Medical Education in Sub-Saharan Africa and Low-Resource Settings: Viewpoint
por: Barteit, Sandra, et al.
Publicado: (2019)

An intersectional analysis of maternal mortality in Sub-Saharan Africa: a human rights issue
por: Batist, Judah
Publicado: (2019)

SARS-CoV-2 in Malawi: Are we sacrificing the Youth in sub-Saharan Africa?
por: Nandi, Biplap, et al.
Publicado: (2020)

Strengthening Routine Data Systems to Track the HIV Epidemic and Guide the Response in Sub-Saharan Africa
por: Rice, Brian, et al.
Publicado: (2018)

Newborn Mortality in Sub-Saharan Africa: Why is Perinatal Asphyxia Still a Major Cause?
por: Usman, Fatima, et al.
Publicado: (2019)

Pro–poor pathway towards universal health coverage: lessons from Ethiopia
por: Admasu, Kesetebirhan, et al.
Publicado: (2016)

Bridging the Access Gap for Comprehensive Sickle Cell Disease Management Across Sub-Saharan Africa: Learnings for Other Global Health Interventions?
por: Hegemann, Lutz, et al.
Publicado: (2023)

Routine monitoring systems for integrated community case management programs: Lessons from 18 countries in sub–Saharan Africa
por: Guenther, Tanya, et al.
Publicado: (2014)

Where to from here? Policy and financing of integrated community case management (iCCM) of childhood illness in sub–Saharan Africa
por: Rasanathan, Kumanan, et al.
Publicado: (2014)

Post-Ebola Awakening: Urgent Call for Investing in Maintaining Effective Preparedness Capacities at the National and Regional Levels in Sub-Saharan Africa
por: Nzietchueng, Serge, et al.
Publicado: (2019)

Including pregnant and breastfeeding people in trials of novel LAED PrEP agents: perspectives from sub‐Saharan Africa community stakeholders
por: White, Rhonda R., et al.
Publicado: (2023)

How health inequality affect responses to the COVID-19 pandemic in Sub-Saharan Africa
por: Okoi, Obasesam, et al.
Publicado: (2020)

An investment case: the role of advocacy in addressing discrimination of vulnerable and marginalized populations at risk for HIV in sub‐Saharan Africa
por: Were, Nerima, et al.
Publicado: (2021)

Examining Misaligned Incentives for Payers and Manufacturers in Value-Based Pharmaceutical Contracts
por: Kannarkat, Joseph T., et al.
Publicado: (2020)

Strategies for the Assessment of Protein Aggregates in Pharmaceutical Biotech Product Development
por: den Engelsman, John, et al.
Publicado: (2010)

mHealth in Sub-Saharan Africa
por: Betjeman, Thomas J., et al.
Publicado: (2013)

Health governance in Sub-Saharan Africa
por: Mooketsane, Keneilwe Sadie, et al.
Publicado: (2015)

Meeting on Establishment of Consortium to Study Invasive Salmonelloses in Sub-Saharan Africa
por: Clemens, John D.
Publicado: (2009)

What are the obligations of pharmaceutical companies in a global health emergency?
por: Emanuel, Ezekiel J, et al.
Publicado: (2021)

The Manufacturers’ Perspective on World Health Organization Prequalification of In Vitro Diagnostics
por: Morin, Sébastien, et al.
Publicado: (2018)

COVID-19 preparedness: capacity to manufacture vaccines, therapeutics and diagnostics in sub-Saharan Africa
por: Bright, Bisi, et al.
Publicado: (2021)

Access to health care in sub-Saharan Africa
por: Dechambenoit, Gilbert
Publicado: (2016)

Mental health services in sub-Saharan Africa
por: Skuse, David
Publicado: (2008)

Vaccinology in sub-Saharan Africa
por: Moïsi, Jennifer, et al.
Publicado: (2019)

Depression in Sub-Saharan Africa
por: Gbadamosi, Ismail Temitayo, et al.
Publicado: (2022)

Contribution of Illicit Drug Use to Pharmaceutical Load in the Environment: A Focus on Sub-Saharan Africa
por: Ripanda, Asha S, et al.
Publicado: (2022)

Ebola and the need for restructuring pharmaceutical incentives
por: Karan, Abraar, et al.
Publicado: (2015)

The manufacturing output effects of infrastructure development, liberalization and governance: evidence from Sub-Saharan Africa
por: Nnyanzi, John Bosco, et al.
Publicado: (2022)

Adolescent Health, Global Guidelines Versus Local Realities: The Sub-Saharan Africa Experience
por: Dube, Kudakwashe, et al.
Publicado: (2013)

Biotech for Wildlife
Publicado: (1993)

Strengthening capacity for health research in Africa
por: Whitworth, James AG, et al.
Publicado: (2008)

Science-based health innovation in sub-Saharan Africa
por: Al-Bader, Sara, et al.
Publicado: (2010)

Experiences of leadership in health care in sub-Saharan Africa
por: Curry, Leslie, et al.
Publicado: (2012)

One Health capacity building in sub-Saharan Africa
por: Rwego, Innocent B., et al.
Publicado: (2016)

Harmonisation of maternal health biorepositories in sub-Saharan Africa
por: Russell, Donna
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f153ssfoplare0i4vr3ts8e6gg